CTRI/2018/12/016539已完成4 期
A single centre, open label, prospective, randomized, parallel group, comparative study to evaluate efficacy and safety of three different form of Vitamin D repletion strategies with standard treatment (Calcium tablet) in VIT-D3 deficient subjects.
Zim Laboratories Limited0 个研究点目标入组 46 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subject between age of 18 to 65 (both inclusive).
- •2.Subjects who are willing and able to take part and attend all required clinical trial visits, able to understand the information given to them and give written consent.
- •3.Subject having blood 25 OH-Vitamin D3 level of Ë?20 ng/ml.
排除标准
- •1.Creatinine level >=1.9.
- •2.History of hyperparathyroidism, a known risk factor for hyperkalemia.
- •3.History of nephrolithiasis given that hypervitaminosis D can increase the risk of nephrolithiasis.
- •4.Current use of any dose of glucocorticoids, a known risk factor for hypercalcuria.
- •5.History of sarcoidosis, tuberculosis, or Paget disease which are known risk factors for hypercalcemia.
- •6.History of Vitamin D intoxication and Granulomatous diseases.
研究者
相似试验
已完成
不适用
Single Center,Study on Evaluation of use of,â??AYURCOVâ?? as add on therapy for Treatment of SARS-CoV-2 Infection in COVID-19 Patients,at Tertiary Care Center.CTRI/2020/06/026262Bhaktivedanta Hospital and Research Institute120
招募中
不适用
Study to compare efficacy and safety of Therapeutic Vaccination with Intensified schedule plus Pegylated Interferon dual Therapy of Hepatitis B virus Surface Antigen in PatientsDiseases of the digestive systemKCT0001395Seoul National University Hospital150
进行中（未招募）
不适用
A single-center, prospective, open-label, randomized, comparative, and placebocontrolled observation study for effect of using Mobile App-based Human Coaching Program on NAFLDDiseases of the digestive systemKCT0007695Yonsei University Health System, Severance Hospital100
尚未招募
不适用
Prospective, Randomized, Open-label, Single center, Case Control Study To Evaluate Impact Of Eglandin® (Alprostadil) On Incidence Of Antibody-mediated Rejection According To Length Of Use In ABO-incompatible Living Donor Liver Transplant PatientKCT0006115Asan Medical Center160
进行中（未招募）
不适用
An investigation into the administration of Infacort® in human adult volunteersAdrenal InsufficiencyMedDRA version: 14.1Level: LLTClassification code 10001369Term: Adrenal insufficiency NOSSystem Organ Class: 100000004860EUCTR2013-000260-28-GBDiurnal Ltd16